Shortened desensitization leading to a 2-year enzyme replacement therapy with elosulfase alfa
Author:
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine,Immunology and Allergy,Immunology
Reference10 articles.
1. A systematic review of the prevalence of Morquio A syndrome: challenges for study reporting in rare diseases;Leadley;Orphanet J Rare Dis,2014
2. BioMarin Pharmaceutical Inc. Vimizim. Full prescribing information. Available at: https://www.vimizim.com/wp-content/uploads/2018/02/Prescribing-Information.pdf. Accessed January 3, 2021.
3. General considerations on rapid desensitization for drug hypersensitivity—a consensus statement;Cernadas;Allergy,2010
4. Skin test concentrations for systemically administered drugs—an ENDA/EAACI Drug Allergy Interest Group position paper;Brockow;Allergy,2013
5. Management of hypersensitivity reactions to enzyme replacement therapy in children with lysosomal storage diseases;Turgay Yagmur;Ann Allergy Asthma Immunol,2020
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Allergic reactions to enzyme replacement therapy in children with lysosomal storage diseases and their management;Journal of Pediatric Endocrinology and Metabolism;2024-09-04
2. Abbreviation of Desensitization Protocol for Pediatric Patients with Lysosomal Storage Diseases Receiving Enzyme Replacement Therapy;International Archives of Allergy and Immunology;2024-07-17
3. Hypersensitivity reaction during enzyme replacement therapy in lysosomal storage disorders. A systematic review of desensitization strategies;Pediatric Allergy and Immunology;2023-06
4. Desensitization to drugs in children;Allergologia et Immunopathologia;2022-03-01
5. Elosulfase-alfa;Reactions Weekly;2021-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3